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Abstract
Background: The progression of implantation and placentation in ruminants is complex and is regulated by
interplay between sex steroids and local signaling molecules, many of which have immune function. Chemokines
and their receptors are pivotal factors in implantation and vascularization of the placenta. Based on known critical
roles for chemokine receptor 4 (CXCR4) during early pregnancy in other species, we hypothesized that CXCR4 and
its ligand CXCL12 would increase in the endometrium and conceptus in response to implantation in ewes. The
objectives of the current study were to determine if CXCL12 and CXCR4 were upregulated in: endometrium from
pregnant compared to non-pregnant ewes and in, conceptuses, cotyledons, caruncles and intercaruncular tissue.
Methods: Tissues were collected from sheep on Days 12, 13, 14, and 15 of either the estrous cycle or pregnancy
and from pregnant ewes on Days 35 and 50. Blood samples from jugular and uterine vein were also collected on
all days. Conceptuses were collected from mature ewes on Days 13, 15, 16, 17, 21 and 30 of gestation. Real time
PCR was used to determine relative mRNA concentrations for CXCL12 and CXCR4 and Western blot analysis was
employed to confirm protein concentration.
Results: Differences described are P < 0.05. In the endometrium, CXCR4 mRNA and protein was greater on Day 15 of
pregnancy compared to the estrous cycle. CXCL12 and CXCR4 mRNA in conceptuses was greater on Days 21 and 30
compared to earlier days. CXCL12 mRNA was greater in cotyledons on Day 35 compared to Day 50. On Day 35 of
gestation, CXCR4 was greater compared to Day 50 in caruncle and intercaruncular tissue. White blood cells obtained
from jugular and uterine vein collection had the greatest mRNA concentration of CXCL12 on Day 35 of pregnancy.
Conclusions: A comprehensive analysis of CXCL12 and CXCR4 expression in fetal and maternal tissues during early
pregnancy is reported with noteworthy differences occurring during implantation and placentation in sheep. We
interpreted these data to mean that the CXCL12/CXCR4 pathway is activated during implantation and placentation
in sheep and is likely playing a role in the communication between trophoblast cells and the maternal
endometrium.
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Background
The immunological mechanisms that govern success of
pregnancy are multifaceted. A remarkable attribute of
normal pregnancy is the delicate communication that
exists between trophoblast cells and differentiated
maternal cells in the uterus. These cells communicate
via production of cytokines, chemokines, growth factors
and hormones to establish a unique maternal-fetal
immune environment that contributes to fetal survival
and “programming” of the maternal uterus until parturi-
tion [1-5]. Interest in chemokines and their receptors
during implantation has grown tremendously in the last
two decades because the endometrial epithelium pro-
duces and secretes chemokines [6,7]. During early gesta-
tion, leukocytes are recruited into the endometrium and
regulation of uterine tissue is thought to be orchestrated
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by an array of chemokines in a precise spatial and tem-
poral pattern [8,9].
The progression of implantation and placentation in
ruminants is a complex and prolonged process that is
regulated by interplay between sex steroids and local
signaling molecules, many of which have immune func-
tion. Chemokines and their receptors are pivotal factors
in implantation and vascularization of the placenta. Che-
mokine receptor 4 (CXCR4), is specifically up regulated
in human endometrium during the implantation win-
dow [10] and increased immunostaining for CXCR4 is
observed in cultured endometrial epithelium only when
a blastocyst is present [10,11]. Additionally, varying tem-
poral expression of CXCR4 in human placenta exists,
with much greater CXCR4 expression observed in early
compared to term placenta, suggestive of an important
role for CXCR4 during early placental development [12].
CXCR4 is expressed in a multitude of tissues and cell
types, including neutrophils, all B cells and monocytes,
the majority of T-lymphocytes, endothelial cells, and
epithelial cells [13] and its primary ligand is the stromal
derived factor-1, also known as CXCL12.
The role of CXCR4 is also implicated in cross talk
between trophoblasts and endometrium by recruiting
lymphocytes into decidua and stimulating trophoblast
proliferation and invasion [14-16]. Treatment of tropho-
blast cells with recombinant CXCL12 results in
increased viability and activation of MAPK ERK1/2
pathway suggesting that CXCL12/CXCR4 interactions
play an important role in early pregnancy in humans
[16].
In humans, similar to other mammals, most of the
angiogenesis in the embryo and placenta occurs in the
first trimester, which correlates with intense expression
of CXCR4 in placental tissue from early pregnancies
[12]. It is not surprising that CXCR4 may affect angio-
genesis, as the chemokine system is a major regulator of
angiogenesis as reviewed by Rosenkilde and Schwartz
[17].
A detailed analysis of CXCL12 and CXCR4 in the
ovine endometrium, conceptus, and placental tissue dur-
ing early gestation has not been reported. Based on
known critical roles of CXCR4 during early pregnancy
in other species, we hypothesized that expression of
CXCL12 and CXCR4 in the endometrium and concep-
tus increases during the time of implantation and pla-
centation in ewes to facilitate communication between
trophoblast cells and maternal endometrium. The objec-
tives of the current study were to determine if CXCL12
and CXCR4 was differentially expressed in: endome-
trium from pregnant and non-pregnant ewes on Days
12, 13, 14 and 15; ovine conceptuses on Days 13, 15, 16,
17, 21 and 30 after mating; and cotyledons, caruncles




All experimental procedures using animals were
reviewed and approved by the Colorado State University
Animal Care and Use Committee. Estrus was synchro-
nized in mature, white-faced, western range ewes during
the mid to late luteal phase with two injections of dino-
prost tromethamine (5 mg i.m.; Lutalyse; Pfizer, New
York, NY) administered 4 h apart. Upon detection of
estrus (Day 0) with a caudaepididyectomized ram, ewes
were placed into experimental groups.
For studies comparing estrous cycle versus pregnancy,
ewes (n = 5 to 6 ewes per day) were mated to an intact
or caudaepididyectomized ram and then anesthetized
with sodium pentobarbitol (20 mg/kg, i.v.) on either Day
12, 13, 14, or 15 of the estrous cycle, or Day 12, 13, 14,
15, 35 or 50 of pregnancy. Prior to anesthetization, jugu-
lar venous blood samples were collected for plasma
from each ewe. A midventral laparotomy was performed
to expose the reproductive tract, and uterine venous
blood was collected for plasma. The reproductive tract
was removed, tissues were collected and snap frozen in
liquid nitrogen and stored at -80°C for subsequent RNA
and protein extraction and the ewes were euthanized by
exsanguination. Pregnancy was confirmed by the pre-
sence of a conceptus. Blood samples were centrifuged
(30 min, 2500 × g, 4°C), white blood cells were removed
and placed in Tri Reagent BD (Molecular Research Cen-
ter, Inc. Cincinnati, OH) and then stored at -80°C for
RNA isolation.
Conceptuses were collected from mature crossbred
ewes on Days 13, 15, 16, 17, 21, and 30 of gestation (n
= 4 to 6 conceptuses per day), as previously described
by Purcell and colleagues [18]. Briefly, for collection of
Day 13 conceptus tissues, ewes were superovulated by
twice-daily i.m. injections for 4 days of follicle-stimulat-
ing hormone (FSH; 30, 30, 20, 20, 10, 10, 10, and 10 mg
of Folltropin; Bioniche, Belleville, ON, Canada) begin-
ning on Day 7 of the estrous cycle. Dinoprost trometha-
mine (Lutalyse; Pfizer, New York, NY) was administered
in two doses (5 mg, i.m., per dose) given 4 h apart
beginning at the time of the sixth FSH injection. Con-
ceptuses on Days 15 through 30 of gestation were col-
lected from ewes synchronized by two injections (10
mg, i.m.) of Lutalyse given 14 days apart. After observa-
tion of standing estrus with a vasectomized ram, all
ewes were bred by one of two intact rams. Pregnant
ewes were sedated using sodium pentobarbital (20 mg/
kg, i.v.), a complete hysterectomy was performed, and
the ewes were euthanized (90 mg/kg sodium
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pentobarbital, i.v.). Conceptuses were flushed from the
uterus using Dulbecco modified Eagle medium/Nutrient
Mixture F-12 Ham (DMEM/F12; Sigma, St. Louis, MO)
supplemented with 0.25% Fraction V BSA (Sigma)
warmed to 38°C. All recovered conceptuses were placed
into 1.5-ml Eppendorf tubes and briefly centrifuged
before removal of any liquid, and then they were frozen
at -80°C until RNA isolation. For Day 21 and Day 30
conceptuses, the fetus was separated from the tropho-
blast before freezing.
RNA and protein isolation
Total RNA was isolated from sheep tissues (not concep-
tus) using Tri Reagent (Sigma Chemical Co., St. Louis,
MO). Each RNA sample was subjected to RNase-free
DNase treatment (QIAGEN, Valencia, CA) to eliminate
genomic DNA contamination and further purified using
the RNeasy Mini Elute clean up kit (QIAGEN, Valencia,
CA). The quantity and purity of RNA were determined
using a NanoDrop ND-1000 Spectrophotometer. For
conceptuses, total cellular RNA was isolated from indivi-
dual conceptuses using RNeasy kits (Qiagen, Valencia,
CA) according to the manufacturer’s protocol. Quantity
and integrity of RNA were confirmed by the absorbance
ratio at 260:280 nm and by electrophoresis on a 1.2%
formaldehyde denaturing gel and visualization of the
18S and 28S ribosomal subunits. RNA samples were
stored at -80°C until use.
Protein was isolated from ovine tissues (100 mg/sam-
ple) by homogenizing in 1 mL of lysis buffer (20 mM
Tris (pH 8.0), 137 mM NaCl, 10% glycerol, 1% Nonidet
P-40, 0.1% sodium dodecyl sulfate SDS, 0.5% deoxycho-
late, and 0.2 mM phenylmethylsulfonyl fluoride) supple-
mented with protease inhibitor cocktail (Roche, Applied
Science, Indianapolis, IN). Samples were placed on ice
for 15 min and then centrifuged at 10,000 × g for 10
min at 4°C and supernatants subsequently removed and
stored at -80°C. Concentrations of protein were deter-
mined using BCA protein assay (Pierce, Rockford, IL).
Real-time PCR (qPCR)
Synthesis of cDNA was accomplished by using the
iScript cDNA Synthesis Kit employing the reverse tran-
scriptase (RT) RNAse H+ (Bio-Rad Laboratories, Her-
cules, CA) per manufacturer’s instructions. The RT
products were diluted to a final volume of 100 μL. Real-
time PCR (qPCR) was performed using a LightCycler
480 PCR Detection System (Roche Applied Science,
Indianapolis, IN) and components of the iQ SYBR
Green supermix (Bio-Rad Laboratories, Hercules, CA),
0.525 μM forward and reverse specific primers, and 2
μL of cDNA. The specific primers employed included:
GAPDH forward primer, 5’-TGACCCCTTCATT-




CXCR4 forward primer, 5’-AAGGCTATCAGAAGCG-
CAAG-3’, CXCR4 reverse primer, 5’-GAGTCGATGCT-
GATCCCAAT-3’. Amplicon size was between 100 and
150 base pairs for each primer set. The PCR efficiency
for primer sets was assessed using cDNA standards, and
each amplified at 95-110% efficiency over a broad
(10,000 fold change in cDNA concentration) target
range. The qPCR conditions were 95°C for 3 min fol-
lowed by 40 cycles of 95°C (30 sec), 55°C (30 sec), 72°C
(15 sec) and then a melt curve was performed per man-
ufacture’s conditions. All primer sets produce only one
product, and the amplicon produced by each primer
pair was sequenced to ensure that each gene of interest
was correctly amplified. GAPDH expression did not
change due to pregnancy status or gestational age and
was used to normalize each target mRNA by using the
ΔCt (target Ct - GAPDH Ct) values [19]. Data are
represented by graphing 2-ΔCt values calculated for each
gene of interest.
Western blot analysis
Protein lysates were collected from ovine tissues as
described above. Equal concentrations of protein (20 μg
per well for endometrium and intercaruncle and 50 μg
per well for caruncle) were separated by SDS-PAGE
using 10% polyacrylamide gels followed by transfer to
nitrocellulose membrane for immunoblotting. Samples
were analyzed for CXCR4 by Western blot analysis
using an anti-CXCR4 antibody (sc-9046, Santa Cruz
Biotechnology, Inc. Santa Cruz, CA) at 1:1000 dilution
in 5% non-fat milk made in Tris-buffered saline plus
tween (TBST). A secondary goat anti-rabbit IgG-horse-
radish peroxidase antibody (Santa Cruz Biotechnology,
Inc. Santa Cruz, CA) at a dilution of 1:5000 was used
for all Western blots. Proteins were detected using the
Amersham ECL Plus Western Blotting Detection System
(Amersham Pharmacia Biotech). Samples from ewes for
each tissue analyzed (endometrium, caruncle, and inter-
caruncle), were subjected to electrophoresis on a single
polyacrylamide gel and transferred to nitrocellulose.
ECL signals were detected with a Storm imager and
quantified with ImageQuant TL software (Amersham
Pharmacia Biotech). An anti-actin antibody (sc-47778;
Santa Cruz Biotechnology) was used at 1:1000 dilution
for all Western blots to further demonstrate equal
loading.
Statistical analysis
Significant changes for the qPCR data were determined
at P < 0.05 using an unpaired, two-tailed Student’s t-test
on normalized Ct values. Signals on western blots were
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scanned with a Storm imager and significant changes
were determined at P < 0.05 using an unpaired, two-
tailed Student’s t-test.
Results
CXCL12 mRNA was detected in the endometrium on
all days tested but did not differ between pregnant and
non-pregnant ewes (Figure 1A). CXCR4 mRNA was
greater (P < 0.05) in the endometrium from pregnant
compared to non-pregnant ewes on Day 15 of gestation
(Figure 1B). Consistent with the increase in CXCR4
mRNA, an increase in CXCR4 protein production in the
endometrium from pregnant ewes on Day 15 of gesta-
tion was confirmed by Western blot analysis (Figure 2).
To determine if gene expression for CXCL12 and
CXCR4 changes in conceptuses during early gestation,
qPCR was performed. CXCL12 and CXCR4 mRNA in
ovine conceptuses exhibited a similar expression pattern
across days tested increasing significantly (P < 0.05) in a
time-dependent fashion by Day 21 of gestation, with the
greatest expression noted on Day 30 (Figure 3).
To assess specific changes at the maternal/fetal inter-
face, cotyledon, caruncle, and intercaruncle tissues were
evaluated for CXCL12 and CXCR4. CXCL12 mRNA
was greater (P < 0.05) in cotyledons on Day 35 com-
pared to Day 50 (Figure 4A), whereas CXCR4 did not
differ in cotyledon tissue between these two gestational
ages (Figure 4B). On Day 35 of gestation, mRNA for
CXCR4 was greater compared to Day 50 in both carun-
cle and intercaruncular tissue (Figure 4B), while mRNA
for CXCL12 did not differ in these tissues between the
two gestational ages (Figure 4A). To determine if
changes in CXCR4 mRNA correlated with translation,
Western blot analysis was performed using caruncle and
intercaruncle tissue. Consistent with mRNA expression
patterns, CXCR4 protein also was significantly greater
(P < 0.05) in caruncle and intercaruncle tissue on Day
35 compared to Day 50 of gestation (Figure 5).
Figure 1 Expression of mRNA for CXCR4 is greater in the
endometrium on Day 15 of pregnancy (P) compared to Day 15
of the estrous cycle (NP), whereas CXCL12 mRNA
concentrations did not change. CXCL12 (A) endometrial mRNA
did not differ in ewes on Days 12-15 of the estrous cycle or
pregnancy. CXCR4 (B) mRNA was significantly (P < 0.05) increased
on Day 15 of pregnancy compared to Day 15 of the estrous cycle.
Data are represented by graphing 2-ΔCt values, where ΔCt indicates

















































Figure 2 CXCR4 protein concentrations are greater in the
endometrium on Day 15 of pregnancy (P) compared to Day 15
of the estrous cycle (NP). Equal concentrations of endometrial
protein from Day 15 pregnant and non-pregnant ewes were
subjected to SDS-PAGE and Western blot analysis was performed to
verify expression of CXCR4 (A). Data represent a minimum of 3 ewes
per pregnancy status per day. The same protein samples were also
immunodetected for actin to further verify equal loading of protein.
Signals on Western blots were scanned on a STORM imager,
converted to densitometric values, and analyzed. Values represent
the mean ± SEM. Significant differences (P < 0.05) between
endometrium from NP and P ewes are indicated by an asterisk (B).
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CXCL12 mRNA in white blood cells from jugular and
uterine vein blood samples was detected in non-pregnant
and pregnant ewes on Days 12, 13, 14, and 15 but did not
differ. However, on Day 35 of pregnancy, CXCL12
mRNA in white blood cells from jugular blood samples
was greater (P < 0.05) compared to Days 13, 14 and 15
(Figure 6A). In uterine vein blood samples, mRNA for
CXCL12 in white blood cells displayed a pattern similar
to jugular vein blood with greater (P < 0.05) CXCL12
mRNA on Day 35 of gestation compared to Days 15 and
50 of gestation (Figure 6B). CXCR4 mRNA in white
blood cells from jugular vein and uterine vein blood
samples was detected on all days evaluated, but did not
differ in pregnant or non-pregnant ewes. (Figure 6).
Discussion
Unlike many other chemokine receptors, CXCR4 has
only one recognized ligand, CXCL12 [20]. The
CXCL12/CXCR4 system is implicated in cross talk
between trophoblasts and endometrium, recruitment of
lymphocytes into the uterus of pregnant females and
vascularization. Based on known critical functions of
CXCR4 activation during early pregnancy in other spe-
cies, we hypothesized that CXCL12 and CXCR4 in the
endometrium and conceptus increased in response to
implantation and placentation in ewes to facilitate com-
munication between trophoblast cells and maternal
endometrium. To test this hypothesis, our first study
investigated the expression of CXCL12 and CXCR4 in
endometrium from pregnant and non-pregnant sheep.
Figure 3 CXCL12 and CXCR4 mRNA is upregulated in
conceptuses during early gestation. CXCL12 (A) and CXCR4 (B)
mRNA are significantly (P < 0.05) upregulated in ovine conceptuses
on Day 21 compared to earlier days collected. Both CXCL12 and
CXCR4 transcripts are also significantly (P < 0.05) upregulated on
Day 30 of pregnancy compared to Days 13, 15, 16, 17, and 21. Data
are represented by graphing 2-ΔCt values, where ΔCt indicates
GAPDH normalized Ct values. Data represent the mean ± SEM.
Figure 4 Upregulation of mRNA for CXCL12 and CXCR4 on Day
35 compared to Day 50 of pregnancy in cotyledon (Cot),
caruncle (Car) and intercaruncle (Intercar) tissue. CXCL12 (A) was
significantly (P < 0.05) greater in cotyledon tissue on Day 35
compared to Day 50 of gestation. CXCR4 (B) was significantly (P <
0.05) elevated in caruncle and intercaruncle tissue on Day 35
compared to Day 50 of pregnancy. Data represent 2-ΔCt values,
where ΔCt indicates GAPDH normalized Ct values. Data represent
the mean ± SEM.
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CXCR4 was consistently expressed in pregnant ewes
across days tested, with decreasing CXCR4 in the endo-
metrium from non-pregnant ewes with advancing days
of the estrous cycle. On Day 15 of pregnancy we
observed greater (P < 0.05) mRNA and protein for
CXCR4 in the endometrium from pregnant compared
to non-pregnant ewes. By Day 15 of gestation initial
attachment of the conceptus to maternal endometrium
begins in sheep [21]. As signal transduction pathways
activated by the CXCL12/CXCR4 axis are known to reg-
ulate adhesion, as reviewed by Kucia and colleagues
[22], it is plausible that CXCR4 may play a role during
attachment. However, further study needs to be con-
ducted to ascertain the role of CXCL12/CXCR4 signal-
ing during implantation.
Coupled with initial attachment of the conceptus to
maternal endometrium, recent studies reported by Gra-
zul-Bilska and co-workers have demonstrated that
angiogenesis is initiated very early in gestation as
reflected by proliferation of capillary endothelial cells, as
early as Day 16 of pregnancy in sheep [23]. The most
potent inducer of both angiogenesis and microvascular
permeability identified so far is vascular endothelial
growth factor (VEGF). Gene-knockout (KO) studies
have provided convincing evidence for a central role of
VEGF in fetal and placental angiogenesis. A lack of even
a single allele of VEGF or VEGFRs results in defective
fetal and placental vasculogenesis and angiogenesis, cul-
minating in embryonic death by mid-gestation [24-27].
Another potent angiogenic factor, basic fibroblast
growth factor (bFGF, or FGF2), stimulates proliferation
of both uterine arterial and fetal placental arterial
endothelial cells [28-31] and is produced by both fetal
and maternal placental tissues [32-35]. Thus, bFGF may
function as an angiogenic factor during placentation.
Interestingly, both VEGF and bFGF increase expression
of CXCR4, but not other chemokine receptors [36].
Subcutaneous injection of CXCL12 into mice induces
formation of local small blood vessels accompanied by
leukocyte infiltration [37]. CXCL12 binding with
CXCR4 on endothelial cells further amplifies angiogen-
esis by inducing more VEGF release [37,38]. VEGF and
bFGF not only induce CXCR4, but also enhance
CXCL12 production by endothelial cells [39], establish-
ing a positive-feedback loop in which VEGF induces
CXCR4 and CXCL12 expression, and conversely
CXCL12/CXCR4 interactions enhance VEGF expression
by these cells, consequently linking classic angiogenic
factors to chemokine-induced angiogenesis. CXCL12/
CXCR4 interactions induce expression of other angio-
genic signals as well, specifically prostacyclin production
by endothelial cells [40]. It should be emphasized that
despite expression of multiple functional chemokine





















































































Figure 5 CXCR4 protein concentrations are greater in caruncle and intercaruncle tissue on Day 35 compared to Day 50 of pregnancy.
Equal concentrations of caruncle and intercaruncle protein lysate from Days 35 and 50 of gestation were subjected to SDS-PAGE and Western
blot analysis was performed to verify expression of CXCR4. Data are representative blots of a minimum of 3 ewes per day. CXCR4 was greater in
caruncle (A) and intercaruncle (B) tissues on Day 35 compared to Day 50 of gestation. The same protein samples were also probed for actin to
further verify equal loading of protein. Signals on Western blots were scanned on a STORM imager, converted to densitometric values, and
analyzed. Values represent the mean ± SEM. Significant differences (P < 0.05) in caruncle (C) and intercaruncle tissues (D) from ewes on Day 35
and 50 are indicated by an asterisk.
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interactions are necessary for some, but not all types of
angiogenesis [36]. Further, only CXCL12 and CXCR4
KO mice exhibit vascular abnormalities compared to
other chemokines and their receptors [41]. Defects in
vascularization have not been observed in any other
chemokine receptor or ligand KO mice, thus their
angiogenic role is, if anything, redundant.
The above provides strong support for CXCL12/
CXCR4 interactions during vascularization and it is con-
ceivable similar functions exist during placental develop-
ment, which is characterized by extensive
vascularization. In the present study CXCR4 increases
between Days 15 and 35 of pregnancy with peak expres-
sion noted on Day 35 in maternal endometrium and
subsequently decreasing by Day 50 of gestation. Interest-
ingly, CXCL12 mRNA in white blood cells from both
jugular and uterine vein samples exhibited a similar
expression pattern, with peak CXCL12 observed on Day
35 of pregnancy when the greatest expression of CXCR4
is observed in the endometrium. The combined data are
curious with respect to the timeframe of early pregnancy
in sheep as the process of attachment and placentation
is a prolonged process with initial attachment beginning
on Day 15-16 of gestation, endometrial vascularization
increasing on Days 20-22 and placentation not complete
until Days 50-60 of pregnancy [23,42-44]. In our study,
peak expression of CXCR4 in caruncle and intercaruncle
tissue is observed on Day 35 compared to Day 50, when
placentation should be close to completion. Given the
strong role CXCR4 plays in vascularization in other sys-
tems, it is probable that activation of CXCR4 is also
driving similar functions during placentation.
The present study demonstrated that mRNA for
CXCL12 and CXCR4 in ovine conceptuses is increased
from Day 17-21, which is intriguing as this time frame
correlates with apposition of trophoblast cells with lumi-
nal epithelium of the endometrium where adhesion
complexes are formed by Day ~21-22 [21,45]. Also,
from Day 21-30 of gestation, during placentation, a dra-
matic increase in trophoblast CXCR4 and CXCL12 is
Figure 6 CXCL12 mRNA is greater in white blood cells from jugular and uterine vein samples during pregnancy, while CXCR4 mRNA
did not change. CXCL12 (A) was significantly (P < 0.05) elevated in white blood cells from the jugular vein on Day 35 compared to Days 12,
13, 14, or 15 of gestation. CXCL12 (B) in white blood cells from uterine vein blood samples were also significantly (P < 0.05) elevated on Day 35
compared to Days 15 and 50 of pregnancy. CXCR4 (C, D) was detected in white blood cells collected on each day of pregnancy, but did not
differ. Data are represented by graphing 2-ΔCt values, where ΔCt indicates GAPDH normalized Ct values. Data represent the mean ± SEM.
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noted in conjunction with the increased CXCR4 (mRNA
and protein) in endometrium of pregnant ewes from
Day 15-35. Literature with respect to CXCL12 and
CXCR4 in ruminants is limited, but in women, activa-
tion of CXCR4 causes recruitment of lymphocytes into
decidua and stimulates trophoblast proliferation and
invasion [14-16]. Trophoblasts secrete CXCL12, which
binds to CXCR4 on decidual cells resulting in increased
activity of matrix metalloprotease (MMP) 9 and MMP2
[46]. MMP9 and MMP2 are critical determinants for
trophoblast migration and invasion [47,48]. Wu and co-
workers [16] demonstrated increased viability of tropho-
blast cells and activation of MAPK ERK1/2 pathway in
trophoblast cells treated with recombinant CXCL12,
suggesting that CXCL12/CXCR4 interactions play an
important role in early pregnancy. In support of these
findings, Jaleel and co-workers [49] showed CXCL12/
CXCR4 signaling suppressed apoptosis and enhanced
trophoblast survival through the MAPK pathway and
speculated that a lack of CXCL12/CXCR4 signaling may
result in significant utero-placental pathology. Activation
of CXCR4 by CXCL12 also promotes CD4+ T-cell survi-
val and increases expression of cell survival genes while
inactivating pro-apoptosis genes such as Bcl2 [50]. In
pregnant mice, CXCL12 causes migration of CXCR4+
Treg cells into the uterus and prevents embryo loss [51].
Therefore, the CXCL12/CXCR4 system may affect
migration of immunocompetent cells into the uterus
and aid in establishment and maintenance of maternal
tolerance to the fetal allograft. In support of this in the
ovine model, the percentage of endometrial CD45R+
lymphocytes is greater in early pregnant ewes compared
to cyclic ewes [52,53], but whether CXCL12/CXCR4
activation is functioning to drive this migration in sheep
is not known. To date, no research has been conducted
on CXCL12/CXCR4 interactions in placenta during
early pregnancy in sheep. We interpreted the data from
the current study to mean the CXCL12/CXCR4 pathway
is activated during implantation and placentation in
sheep and is likely playing a role in the communication
between trophoblast cells and the maternal
endometrium.
In summary, we have described upregulation of a
unique chemokine, CXCL12 and its receptor, CXCR4
during early pregnancy in sheep in both fetal and mater-
nal tissues. Historically, study of chemokines and their
respective receptors have focused specifically on
immune functions, yet research into their biological
roles in other systems has grown extending the func-
tional implications of chemokine receptor activation.
The unique relationship between VEGF, bFGF and the
CXCL12/CXCR4 system may provide novel insights into
the temporal changes in expression of select angiogenic
factors and their functions during placentation. In rumi-
nants, interferon tau (IFNτ) is produced by trophoblast
cells and serves as the classic signal for maternal recog-
nition of pregnancy. Pertinent to the current study,
CXCL12 was recently identified as a new IFNτ induced
gene in cattle [54]. Whether similar gene regulation is
observed in sheep is not known, but underscores the
communication that exists between trophoblast cells
and the maternal endometrium during early gestation
with regards to the CXCL12/CXCR4 system. In conclu-
sion, data from the current study provides a solid foun-
dation for future study of CXCL12 and CXCR4
functions during implantation and placentation, specifi-
cally vascularization of the placenta and highlights the
novel roles CXCL12/CXCR4 signaling may have during
early pregnancy.
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